证券日报网讯 10月24日晚间，天准科技发布公告称，公司于2025年10月24日召开第四届董事会第二十 二次会议，审议通过了《关于调整公司2021年限制性股票激励计划授予价格的议案》《关于作废2021年 限制性股票激励计划部分限制性股票的议案》。鉴于2024年利润分配方案已实施完毕，根据公司《2021 年限制性股票激励计划》的相关规定：本激励计划公告日至激励对象获授限制性股票前，以及激励对象 获授限制性股票后至归属前，公司有资本公积转增股本、派送股票红利、股份拆细、配股、缩股或派息 等事项，应对限制性股票的授予价格进行相应的调整，2021年限制性股票激励计划调整后的授予价格为 16.6268元/股。根据公司《2021年限制性股票激励计划》《2021年限制性股票激励计划实施考核管理办 法》的相关规定，1名激励对象因离职而不具备激励对象资格，作废处理其已获授但尚未归属的限制性 股票合计3.00万股。 （编辑 任世碧） ...

Core Viewpoint - The company has completed the repurchase and cancellation of 1,784,100 restricted stocks, which accounts for 0.29% of the total share capital prior to the repurchase, with a total repurchase amount of RMB 6,075,789 [2][3][18] Group 1: Repurchase Details - The repurchase involved 78 individuals and was executed due to the departure of one incentive object who no longer met the criteria of the incentive plan [2][9] - The repurchase price for the initially granted restricted stocks was adjusted from RMB 3.69 per share to RMB 3.29 per share, and for the reserved stocks from RMB 4.59 per share to RMB 4.29 per share [2][14] - After the cancellation, the company's total share capital changed from 623,708,628 shares to 621,924,528 shares [3][16] Group 2: Performance and Compliance - The company did not meet the performance assessment targets set for the incentive plan, leading to the repurchase of 155,100 shares from 61 incentive objects and 20,610 shares from 16 reserved incentive objects [10][11] - The repurchase was conducted in accordance with the regulations of the incentive plan and relevant laws, ensuring compliance with corporate governance [16][18] Group 3: Financial Impact - The repurchase and cancellation of restricted stocks are not expected to have a substantial impact on the company's financial status or operational results [18] - The company's equity structure remains compliant with listing requirements, and there will be no change in control for the major shareholders [18]

Core Viewpoint - The company announced the repurchase and cancellation of unvested restricted stock from its 2021 equity incentive plan, adjusting the repurchase price in the process [1][4][6]. Group 1: Decision Process and Disclosure - The board of directors and the supervisory board have approved the repurchase of unvested restricted stock through multiple meetings, ensuring compliance with legal and regulatory requirements [2][4][8]. - The company has publicly disclosed the names and positions of the intended recipients of the equity incentive plan, with no objections received during the public notice period [2][3]. Group 2: Repurchase Details - The repurchase is due to the failure to meet performance targets outlined in the equity incentive plan, affecting 140 individuals and corresponding to 25% of the total granted restricted stock [5][8]. - The total number of restricted stocks to be repurchased is 1,369,375 shares, which represents 18.82% of the total granted shares and 0.11% of the company's total share capital [6][8]. Group 3: Financial Impact and Future Arrangements - The repurchase will be funded through the company's own funds, amounting to a total of 11.8748 million yuan [6]. - Post-repurchase, the company's total share capital will decrease from 1,199,724,419 shares to 1,198,355,044 shares, with a reduction in restricted shares from 3,819,270 to 2,449,895 [6][8]. - The company will comply with relevant regulations for the cancellation process and will fulfill its information disclosure obligations [6][9].

Core Points - The company held its 11th Board of Directors' second meeting on August 27, 2025, where several key resolutions were passed [1] - The meeting was conducted in accordance with the Company Law of the People's Republic of China and the company's articles of association [1] Group 1: Financial Reports and Evaluations - The Board approved the "2025 Semi-Annual Report" and its summary, which had been reviewed by the Audit Committee and the Strategy and ESG Committee prior to the meeting [2] - The Board also approved the semi-annual evaluation report of the "Quality Improvement and Efficiency Enhancement Action Plan for 2025" [2] Group 2: Stock Incentive Plans - The Board approved the achievement of conditions for the fourth unlock period of the 2021 Restricted Stock Incentive Plan, allowing 29 eligible participants to unlock their restricted stocks [3] - The Board decided to adjust the repurchase prices for the restricted stocks under the 2021 Incentive Plan, reducing the repurchase price from 6.0415 CNY/share to 4.1015 CNY/share for the initial grant and from 6.0225 CNY/share to 4.0825 CNY/share for reserved grants [3][4] - The Board approved the repurchase and cancellation of 100.25 million shares of restricted stock due to performance evaluations and departures of certain incentive participants [5] Group 3: Future Plans and Proposals - The Board approved the adjustment of the repurchase price for the 2025 Restricted Stock Incentive Plan, with specific details to be disclosed [6] - The Board also approved the repurchase and cancellation of 20,000 shares of restricted stock for a participant who no longer meets the eligibility criteria due to departure [7] - The Board proposed to hold the second temporary shareholders' meeting of 2025 to discuss related matters, with details to be announced later [8]

Core Viewpoint - Jiangzhong Pharmaceutical Co., Ltd. is implementing a buyback and cancellation of certain restricted stocks as part of its 2021 stock incentive plan, which aims to enhance employee motivation and ensure sustainable development [1][5][10]. Summary by Sections Legal Framework - The legal opinion is based on the Company Law, Securities Law, and relevant regulations regarding stock incentive management [2][3]. - The law firm confirms that the company has provided all necessary and truthful documentation for the issuance of this legal opinion [3]. Buyback Authorization - The buyback plan has been approved by the company's board and is in compliance with the relevant legal requirements [4][10]. - The company aims to establish a long-term incentive mechanism to motivate core employees and does not harm the interests of the company or its shareholders [5][10]. Buyback Details - The buyback is due to certain employees no longer meeting the incentive conditions, resulting in the cancellation of 42,733 shares, which is 0.0067% of the total share capital [11]. - The adjusted buyback price is set at 2.0998 yuan per share, based on previous cash dividends [12][13]. - The total amount for the buyback is 89,730.75 yuan, sourced from the company's own funds [12][13]. Conclusion - The legal opinion concludes that the company has fulfilled the necessary legal procedures for the buyback and cancellation of shares, and further actions will be taken in accordance with relevant regulations [13].

Core Viewpoint - The company has decided to terminate the 2021 Restricted Stock Incentive Plan and cancel the repurchased shares, which will also lead to a reduction in registered capital due to changes in market conditions and the company's operational adjustments [1][3][6]. Group 1: Termination of Incentive Plan - The board of directors and the supervisory board have approved the termination of the 2021 Restricted Stock Incentive Plan and the cancellation of 10,408,656 repurchased shares [1][3]. - The decision to terminate the incentive plan was made after careful consideration, as the original performance targets were deemed unattainable under current market conditions [3][6]. Group 2: Share Repurchase and Capital Reduction - The company has repurchased a total of 10,408,656 shares, which represents approximately 0.79% of the total share capital, with a total expenditure of 34,112,473.58 yuan [2][5]. - Following the cancellation of the repurchased shares, the registered capital will decrease from 1,315,878,571 yuan to 1,305,469,915 yuan [5][6]. Group 3: Compliance and Approval Process - The termination of the incentive plan and the cancellation of shares will require approval from the shareholders' meeting [1][5][7]. - The supervisory board has confirmed that the actions taken are in compliance with relevant laws and regulations, ensuring no adverse impact on the company's operations or shareholder interests [7][8].

Core Points - The company held its 13th meeting of the 10th Supervisory Board on June 27, 2025, to discuss the achievement of conditions for the third release period of the 2021 Restricted Stock Incentive Plan [1] - The meeting approved the release of 37.98075 million shares of restricted stock for 519 incentive targets, confirming that the conditions for the release have been met and are in compliance with relevant laws and regulations [1][2] Summary by Sections Meeting Details - The meeting was conducted via communication methods with 5 supervisors participating in the vote, meeting legal and regulatory requirements [1] Incentive Plan - The 2021 Restricted Stock Incentive Plan's third release period conditions have been achieved, allowing for the legal and valid release of restricted stock for the designated incentive targets [1] - The approval was unanimous with 5 votes in favor and no votes against or abstentions [1]

Core Viewpoint - The company has completed the procedures for the third unlock period of the restricted stock incentive plan, allowing for the circulation of shares that were previously restricted [1][7]. Summary by Sections Incentive Plan Approval and Execution - The company has conducted the necessary approval procedures for the 2021 restricted stock incentive plan, including the review and approval of relevant proposals by the board and the supervisory committee [2][3]. - The initial grant of restricted stock involved 173 individuals, with a total of 1.6477 million shares granted, and the listing date for these shares was December 24, 2021 [2]. Unlocking Conditions and Performance Assessment - The third unlock period for the restricted stock is defined as the period from 42 months after the initial grant registration to the last trading day within 54 months from the grant date, allowing for 40% of the total granted shares to be unlocked [7]. - The company has confirmed that the conditions for unlocking the third period have been met, with 143 individuals eligible to unlock a total of 1,787,948 shares [7][18]. Changes in Share Structure - Following the unlocking of shares, the total number of shares with restrictions decreased from 77,083,531 to 75,295,583, while the total number of unrestricted shares increased from 151,904,648 to 153,692,596 [18]. - The total share capital of the company remains at 228,988,179 shares after the adjustments [18]. Adjustments to the Incentive Plan - The number of individuals participating in the incentive plan has been adjusted due to personal reasons leading to the forfeiture of shares by some participants, resulting in a reduction of the total granted shares [14][15]. - The company has also conducted buybacks of restricted shares from individuals who no longer qualify for the incentive plan due to leaving the company [5][16].

Core Viewpoint - The independent financial advisor report indicates that the conditions for the fourth vesting period of the initial grant and the third vesting period of the reserved grant under the 2021 restricted stock incentive plan of Aibo Medical have been met [1][12]. Summary by Sections Company Overview - Aibo Medical, officially known as Aibo Nord (Beijing) Medical Technology Co., Ltd., is involved in a restricted stock incentive plan aimed at motivating key personnel [1]. Incentive Plan Details - The initial grant's fourth vesting period is defined as the period from the first trading day after 48 months from the grant date to the last trading day within 60 months from the grant date, which is set from June 16, 2021, to June 15, 2026 [8]. - The reserved grant's third vesting period is defined as the period from the first trading day after 36 months from the reserved grant date to the last trading day within 48 months from the reserved grant date, set from March 31, 2025, to March 27, 2026 [11]. Performance Conditions - For the initial grant, the company must achieve an average compound growth rate of adjusted net profit of 35% for the year 2024, with the actual growth rate reported at 44.87%, thus meeting the performance target [10]. - The performance assessment for individual participants is categorized into four levels: Excellent, Good, Qualified, and Unqualified, determining the actual number of shares vested based on company and individual performance [10][11]. Approval Process - The incentive plan underwent several approval stages, including board meetings and shareholder meetings, with necessary independent opinions and verification from the supervisory board [6][7][8]. Independent Advisor's Opinion - The independent financial advisor confirms that the conditions for the vesting of the restricted stock have been fulfilled and that the relevant matters have received the necessary authorizations and approvals [12].

Core Viewpoint - The legal opinion letter from Deheheng Law Firm confirms that Beijing Huafeng Measurement and Control Technology Co., Ltd.'s stock incentive plan has met the necessary conditions for the fourth vesting period and the third reserved grant period, along with adjustments to the grant price and the cancellation of certain restricted stocks [1][8][14]. Group 1: Approval and Authorization of the Incentive Plan - The incentive plan has been approved and authorized through various resolutions, including the draft of the 2021 Restricted Stock Incentive Plan and the assessment management measures [4][5][6]. - Independent directors and the supervisory board have provided opinions confirming that the incentive plan is beneficial for the company's sustainable development and does not harm the interests of shareholders [4][6]. Group 2: Vesting Conditions - The first vesting period for the incentive plan is set from May 27, 2021, to May 26, 2026, with specific conditions that must be met for the vesting to occur [8][11]. - The conditions for vesting include the absence of negative audit opinions on financial reports and compliance with legal regulations regarding profit distribution [8][10]. Group 3: Adjustments to Grant Price - The grant price has been adjusted due to changes in the company's profit distribution plan, with the new adjusted price being 66.65 RMB per share [13][14]. - The adjustment method follows the formula where the new price is calculated based on the previous price minus the dividend per share [13]. Group 4: Cancellation of Restricted Stocks - A total of 18,136 shares of restricted stock have been canceled due to the departure of one incentive object and the voluntary relinquishment of another [14]. - The board and supervisory board have agreed that the cancellation complies with relevant laws and does not harm shareholder interests [14]. Group 5: Information Disclosure Obligations - The company is required to disclose relevant documents related to the vesting, adjustment, and cancellation of stocks within two trading days following the board meetings [14]. - The company will continue to fulfill its legal obligations for information disclosure as the incentive plan progresses [14].